NCT06722846 Communicating Health Options to Inform Care and Empower Strategic Care Planning (CHOICES): A Multi-layer Randomized Case Vignette Study.
| NCT ID | NCT06722846 |
| Status | Recruiting |
| Phase | — |
| Sponsor | M.D. Anderson Cancer Center |
| Condition | Health Options |
| Study Type | OBSERVATIONAL |
| Enrollment | 400 participants |
| Start Date | 2024-11-21 |
| Primary Completion | 2026-08-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 400 participants in total. It began in 2024-11-21 with a primary completion date of 2026-08-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
To learn more about how the delivery of medical information affects therapy choices for participants with advanced forms of cancer.
Eligibility Criteria
Inclusion Criteria: Diagnosis of advanced solid tumor (i.e. metastatic, relapsed, and/or incurable disease) or aggressive lymphoma. * Age 18 or greater * Seen at MD Anderson Cancer Center Thoracic and Lymphoma Oncology Clinics for a follow-up visit * Been treated with at least 2 lines of palliative systemic cancer therapies Exclusion Criteria: * Diagnosis of cognitive impairment or dementia requiring a surrogate decision maker * Non-English speaking
Contact & Investigator
David Hui, MD
PRINCIPAL INVESTIGATOR
M.D. Anderson Cancer Center
Frequently Asked Questions
Who can join the NCT06722846 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Health Options. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06722846 currently recruiting?
Yes, NCT06722846 is actively recruiting participants. Contact the research team at dhui@mdanderson.org for enrollment information.
Where is the NCT06722846 trial being conducted?
This trial is being conducted at Houston, United States.
Who is sponsoring the NCT06722846 clinical trial?
NCT06722846 is sponsored by M.D. Anderson Cancer Center. The principal investigator is David Hui, MD at M.D. Anderson Cancer Center. The trial plans to enroll 400 participants.